Clinical Trial Update: Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD [Phase 3]

View source ↗

Summary

An open-label, randomized, multicenter Phase 3 trial comparing on-demand versus continuous esomeprazole in patients with gastroesophageal reflux disease has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED